Univar Acquires Interpur Chemicals
Univar Solutions has acquired Interpur Chemicals, a leading distributor of polyurethanes and powder coatings in Europe.
Mergers & Acquisitions (M&A)
Samsung Biologics to Acquire PolyPeptide in All-Cash Deal, Expanding Global Manufacturing
PolyPeptide's specialized peptide expertise and global multi-site network to strengthen Samsung Biologics' multi-modality and global manufacturing excellence.
Shell Divests India's Sprng Energy in $1.8 Billion Deal with Aditya Birla
Shell has agreed to sell its Sprng Energy renewables business in India to Aditya Birla Renewables for $1.8 billion, as part of its strategy to streamline and improve returns in its power portfolio.
BASF and Carlyle Complete Coatings Transaction
The Coatings transaction between Carlyle and BASF, announced on October 10, 2025, was completed on June 30, 2026.
Ineos Enterprises Completes Sale of Ineos Calabrian to Ecovyst
Ineos Enterprises has completed the sale of Ineos Calabrian, its ultra-pure sulfur dioxide and derivatives business, to Ecovyst.
IMCD Expands in Southeast Asia with Thai Plastics Distributor Acquisition
IMCD is acquiring Merit Solution, a Thai distributor of plastic additives, to strengthen its position in the plastics and compounding market in Thailand and Southeast Asia.
Merck Acquires Life Sciences Company Bio-Techne
Merck has agreed to acquire Bio-Techne in an all-cash deal valuing the company at approximately $11.3 billion.
Chiesi Group Acquires KalVista Pharmaceuticals for $1.9 Billion
Chiesi Group has completed its acquisition of KalVista Pharmaceuticals, marking the Italian biopharmaceutical group's largest deal to date.
Olin and Huntsman Announce Transformative Merger of Equals
Olin and Huntsman, the two major US chemical manufacturers, will create a $12+ billion integrated North American chemicals leader.
GSK Strikes $10.6 Billion Deal for Nuvalent in One of Pharma's Biggest Oncology Acquisitions of 2026
GSK has agreed to acquire US clinical-stage oncology specialist Nuvalent for $10.6 billion, its largest deal in years, to accelerate entry into lung cancer and boost growth through the dolutegravir patent cliff.
Wacker completes sale of shares in Siltronic
Wacker has sold 2.1 million Siltronic shares for € 89.35 per Siltronic share. The sale corresponds to 7% of Siltronic's share capital and reduces Wacker's stake in Siltronic to around 24%.
CordenPharma Acquires AmbioPharm to Expand Peptide API Capacity
Acquisition strengthens US peptide manufacturing capabilities and broadens global expertise in complex peptide APIs
Chemical Solutions Group Adds Resource Chemicals to Growing UK Portfolio
Irish water treatment specialist CSG acquires UK distributor Resource Chemicals, pushing group revenue past €100 million and advancing its strategy to build a full-service platform across Ireland and the UK.
Alcami Completes Tjoapack Acquisition to Bolster Global Packaging Scale
Alcami completes its acquisition of Tjoapack, creating a 1,400-strong CDMO with over one million square feet of operations across the US and the Netherlands, adding European packaging scale and QP release services.
Westlake Vinnolit Takes over Insolvent Vynova Wilhelmshaven
The provisional insolvency administrator of Vynova Wilhelmshaven has signed a letter of intent with the US chemicals group Westlake regarding the acquisition of the production site for polyvinyl chloride and vinyl chloride monomer in Wilhelmshaven.
Shrieve Chemical Company Acquires FIS Chemicals
Shrieve Chemical Company has acquired Aberdeen-based FIS Chemicals, expanding Shrieve’s product portfolio and presence across key industrial end markets; deal terms were not disclosed.
Ineos Inovyn to Sell Italian Chlor-Alkali Business to Esseco
Ineos Inovyn to sell its stake in Italy’s Inovyn Produzione Italia (Rosignano, Tavazzano sites) to Esseco Industrial. Deal expected in 2026, pending approvals; operations and supply unchanged during transition.
Asahi Kasei Completes Acquisition of Aicuris, Expands Antiviral Assets
Asahi Kasei has completed its acquisition of Germany’s Aicuris, adding three antiviral assets, in a deal previously reported at about €780 million.
Gilead to Acquire Tubulis, Strengthing Oncology Pipeline
Acquisition includes industry-leading ADC platform, its clinically-validated tubutecan linker-payload technology, and next-generation platform to expand Gilead’s ADC capabilities.
Colonial Chemical Solutions Acquires Integrity Partners Group
Colonial Chemical Solutions has acquired Integrity Partners Group, adding Chemisphere and Chemsolv to expand its Southeast footprint, capabilities, and customer reach in chemical distribution.
Merck & Co. Deepens Hematology Pipeline with $6.7 Billion Terns Acquisition
Merck has launched its acquisition of Terns Pharmaceuticals, a deal valued at about $6.7 billion that would add to its hematology portfolio.
Prange Pharma Launches Aprilia Animal Health CDMO After MSD Site Acquisition
Prange Pharma has completed its acquisition of MSD Animal Health’s Aprilia site in Italy, which will now operate as Aprilia Animal Health, a new European CDMO platform for the animal health sector.
BASF Completes Acquisition of AgBiTech
BASF Agricultural Solutions recently completed the acquisition of AgBiTech. This follows the agreement signed in January 2026 with private equity firm Paine Schwartz Partners and other shareholders.
Adragos Pharma Completes Acquisition of Sanofi’s Sterile Fill-Finish Site in France
Adragos Pharma has acquired Sanofi’s Maisons-Alfort sterile fill-finish site in France, expanding its European manufacturing network and prefilled syringe capabilities.
Samsung Biologics Acquires GSK’s Manufacturing Facility in Maryland, US
The acquisition marks Samsung Biologics’ geographical diversification, establishing its first US manufacturing presence and expanding regional client support.
Lonza Divests Capsules & Health Ingredients Business for $3 Billion
Lonza signs agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds, for an enterprise value of $3 billion (CHF 2.3 billion).
Kearney Report Signals Chemicals M&A Rebound
Kearney's 2026 Chemicals Executive M&A Report forecasts strengthened global deal activity after 2025 gains, with executives anticipating more small-to-mid-size transactions.
Asahi Kasei Acquires Aicuris for €780 Million
Asahi Kasei will acquire all shares in the German biopharmaceutical company Aicuris Anti-infective Cures for approximately €780 million.
Alkermes Completes $2.1 Billion Acquisition of Avadel Pharmaceuticals
Alkermes has finalized its acquisition of Avadel Pharmaceuticals, bolstering its presence in the sleep medicine market.
Sanofi Completes Acquisition of Dynavax for $2.2 Billion
Sanofi has completed its acquisition of Dynavax, adding its adult vaccines and pipeline candidates to strengthen Sanofi’s presence in adult immunization.
Umicore PMC Integrates HTS and Ligand Services from Solvias
Umicore Precious Metals Chemistry (Umicore PMC) has acquired high-throughput screening (HTS) and specialty ligand technologies from Solvias, with services transitioning during 2026.
Henkel to Acquire Coatings Company Stahl for €2.1 Billion
Henkel has agreed to acquire Dutch-based specialty coatings company Stahl for €2.1 billion to strengthen and expand its Adhesive Technologies business into adjacent high-performance coatings markets.
GSK to Acquire RAPT Therapeutics for $2.2 Billion
GSK announced a definitive agreement to acquire RAPT Therapeutics for $2.2 billion, gaining rights to ozureprubart, a next-generation treatment that could protect food allergy patients.
Agno Pharma Acquires US cGMP API Manufacturing Site
Agno Pharma acquired Actylis's Eugene, Oregon CDMO facility, formerly Cascade Chemistry, for small-molecule API development and manufacturing, thereby expanding its US footprint.
HSH Chemie Group Acquires Two Sweetener Companies
The acquisitions strengthens HSH Chemie’s sweetener and sugar alternatives
portfolio, adding established fructose expertise, long-standing customer
relationships, and international market access.
